For example, the humanized monoclonal antibody against C5 (eculizumab), which inhibits its cleavage to C5a and C5b, promoted a significant improvement in the clinical score of rheumatoid arthritis when administered intravenously [37]. The gene discussed is C5; the disease is rheumatoid arthritis.